Contact us Demo our platform

ON-DEMAND WEBINAR

Unravelling Microbiome Insights with Metabolon’s Microbiome Research Solution

“Combining metabolomics and metagenomics delivers a panoramic view of host–microbe interactions multiplying research outputs in a way single-omics approaches simply cannot.” – Dr. Joe Foster, Metabolon.

Microbiome Research Solution Now Live – Configurable, comprehensive, and ready for every study

Through bespoke combinations of amplicon-based, shotgun sequencing, untargeted metabolomics, and the absolute quantification of shortchain fatty acids, Metabolon’s Microbiome Research Solution puts every analytical decision in your hands, letting you design experiments that fit your exact biological question.

Meaningful discovery happens when quality data, careful interpretation, and intuitive technology come together to reveal clear insights from complexity. Built around the trusted Integrated Bioinformatics Platform (IBP), the Microbiome Tool unifies metagenomic, metabolomic, and phenotypic data within a code-less, accessible platform that simplifies complex analyses without compromising flexibility or analytical depth and rigor. From raw sequencing data to rich visualizations, the platform performs end-to-end processing without requiring manual intervention or custom engineering. Unlike tools that focus solely on taxonomic profiling or single omics correlations, this solution seamlessly connects microbial composition to functional metabolic activity. With this foundation in place, researchers are equipped from the outset to identify the microbes that differentiate sample groups, uncover community-level patterns, and investigate functional variation across taxonomic levels with confidence and ease. Whether the goal is mechanistic discovery or translational application, Metabolon’s Microbiome Tool offers the analytical power and user-friendly experience needed to translate microbiome data into actionable knowledge.

In this webinar, Metabolon scientists walk you through the platform and showcase real world case studies.

What you’ll learn:

  • Microbiome Research Solution Overview – How to configure and create metabolomic and metagenomic datasets into a single, harmonized project.
  • Metagenomics and Metabolomics Complementarity  – What combining these two omic modalities can achieve.
  • Microbiome Analysis Tool – Demonstration of interactive QC, taxonomic profiling, clustering and correlation analysis, and rich visualizations inside IBP.
  • Integrative Multiomics – Using machine-learning to link microbial taxa with metabolite profiles for predictive modelling.
  • Biological Interpretation Service – How expertcurated reports distil complex results into clear narratives and nextstep hypotheses.

Speakers

K
L

Joe Foster, Ph.D.

Strategic Products Director, Metabolon Joe Foster has over 15 years of experience in bioinformatics, spread across genomics, proteomics, lipidomics, and metabolomics. Joe currently serves as Metabolon’s Director of Strategic Products, helping shape the roadmap for the Integrated Bioinformatics Platform and developing Bioinformatics Professional Services that accelerate time to insight with metabolomics and multiomics data. Prior to joining Metabolon, Joe has held a variety of positions across R&D, customer success, Sales Engineering and Business Development for prominent brands in the Life Sciences industry including, Affymetrix, Thermo Fisher Scientific, and DNAnexus. His career highlights include working with the NHS England Genomic Laboratory Hubs to implement Secure and Scalable Clinical Bioinformatics in the cloud and his work with UK Biobank and Our Future Health to deploy a best-in-class Trusted Research Environment. With a PhD in Bioinformatics from the University of Cambridge and the European Bioinformatics Institute, Joe brings a deep scientific foundation and a practical, results-focused approach to solving complex research challenges.
K
L

Joshua Simpson, Ph.D.

Senior Microbiome Scientist, Metabolon

Dr. Joshua Simpson's is an expert in microbial metabolism and its impact on human health. At Metabolon, he develops tools for integrative microbiome analysis and applies them to advance biomarker and drug discovery.

WATCH WEBINAR

Related Webinars

See All Webinars
✕

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.